News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactBook DemoLog in
Start free trial
Foresight logo
All News & Insights

Regulatory Changes for Active Bromine Biocidal Products in Great Britain

BPR
12
February 2024
•
410
Dr Steven Brennan
The absence of support for these bromine-based product types means they are subject to removal from the GB market.
Jar of bromine
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

The Health and Safety Executive (HSE) has issued a critical update on the future of Active Bromine biocidal products in Great Britain. As per the latest ebulletin, a significant shift in the regulation of biocidal products is underway, impacting the availability and use of Active Bromine generated from specific precursor combinations.

Under the Biocidal Products Regulation (GB BPR), which governs the supply and use of biocidal products in Great Britain, several precursor combinations used to generate Active Bromine for biocidal purposes will be phased out of the market. This move comes after industry stakeholders decided to withdraw their support for the necessary safety and efficacy reviews of these substances, required under the GB BPR framework.

The GB BPR, grouping biocidal products into 22 distinct types based on their application, had offered an opportunity for entities to support the review process of biocidal active substances, including those generated in-situ. However, the HSE reports a lack of compliant notifications from the industry to continue support for the following Active Bromine generating combinations:

  • Active bromine generated from bromine chloride in product type 11
  • Active bromine generated from hypobromous acid and urea and bromourea in product types 11 and 12
  • Active bromine generated from sodium bromide and calcium hypochlorite in product type 2
  • Active bromine generated from sodium bromide and chlorine in product type 2
  • Active bromine generated from sodium bromide and sodium hypochlorite in product type 2
  • Active bromine generated from sodium bromide by electrolysis in product type 2
  • Active bromine generated from sodium hypobromite and N-bromosulfamate and sulfamic acid in product type 11

The absence of support for these combinations means they are subject to a non-approval decision by GB BPR, leading to their eventual removal from the GB market. Products containing these active substances will no longer be supplied or utilized in Great Britain following the designated phase-out period.

This regulatory adjustment underscores the commitment of HSE to maintain high safety and efficacy standards for biocidal products. Stakeholders are advised to prepare for the transition and the discontinuation of affected biocidal products.

HSE urges industry members and other stakeholders to report any potential disproportionate negative effects resulting from these changes by 8 March 2024. Detailed updates on the non-approval decisions and the relevant phase-out periods will be provided separately by HSE, ensuring all parties are well-informed and can adapt to the new regulatory landscape.

This development marks a pivotal moment for the biocidal product industry in Great Britain, emphasizing the importance of regulatory compliance and the collective effort to ensure public health and safety.

Read the source story

The Health and Safety Executive (HSE) has issued a critical update on the future of Active Bromine biocidal products in Great Britain. As per the latest ebulletin, a significant shift in the regulation of biocidal products is underway, impacting the availability and use of Active Bromine generated from specific precursor combinations.

Under the Biocidal Products Regulation (GB BPR), which governs the supply and use of biocidal products in Great Britain, several precursor combinations used to generate Active Bromine for biocidal purposes will be phased out of the market. This move comes after industry stakeholders decided to withdraw their support for the necessary safety and efficacy reviews of these substances, required under the GB BPR framework.

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

Defence weaponsEU Proposes to Expand REACH Defence Exemptions to Accelerate Readiness

June 20, 2025

Pet mouseBPC-55: EU Committee Approves Biocide Renewals, Union Authorisations and Technical Updates

June 20, 2025

Personal care productsECHA's Assessment Highlights Potential Risks of Quaternary Ammonium Compounds

January 30, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Defence weapons

EU Proposes to Expand REACH Defence Exemptions to Accelerate Readiness

The EU proposes expanded REACH defence exemptions to fast-track chemical regulatory processes vital to defence readiness and industry compliance.

20

Jun 2025

REACH
POPs
CLP
Pet mouse

BPC-55: EU Committee Approves Biocide Renewals, Union Authorisations and Technical Updates

ECHA’s BPC delivers key decisions on rodenticides, disinfectants, and procedural reforms at its May 2025 meeting. Understand the agenda outcomes.

20

Jun 2025

BPR
Personal care products

ECHA's Assessment Highlights Potential Risks of Quaternary Ammonium Compounds

ECHA's new assessment on quaternary ammonium compounds may have future impacts on disinfectants, pest control, and personal care products.

30

Jan 2025

CLP
REACH
BPR
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy